Implementation of Lung Cancer Screening: Proceedings of a Workshop


Note: Proceedings contain the opinion of the presenters, but do NOT reflect the conclusions of the Health and Medicine Division or the National Academies. Learn more about the differences between Reports and Proceedings.

Lung cancer is the leading cause of cancer-related death in the United States; each year, more people die from lung cancer than from colon, breast, and prostate cancers combined. There has been a push to develop and implement screening strategies for the early detection of lung cancer. The National Lung Screening Trial evaluated the effectiveness of annual screening with low-dose computed tomography to reduce lung cancer mortality among individuals at high risk. The trial found a 20 percent reduction in mortality from lung cancer among individuals at high risk. Subsequently, the U.S. Preventive Services Task Force and clinical practice guidelines have recommended annual lung cancer screening. Broad implementation of lung cancer screening is complex, and the National Cancer Policy Forum held a workshop, “Implementation of Lung Cancer Screening,” to examine the opportunities and challenges involved in developing effective lung cancer screening programs in clinical practice. 

At the workshop, experts discussed the current evidence base for lung cancer screening, best practices for screening programs, incorporation of shared decision making and smoking cessation services in screening, and assessment of patient outcomes, quality, and value in lung cancer screening programs; and research needs that could improve implementation efforts. These proceedings chronicle the presentations and discussions at the workshop.